Friedrich-Alexander-Universität Erlangen-Nürnberg; Medizinische Klinik V

Erlangen 91054

0 studies enrolling now · 2 studies all time

What they study most

Bladder Cancer, Diffuse Large B-Cell Lymphoma

Studies at this site

• A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] — Completed
• A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA) — Stopped early